Skip to main content

Table 1 Patients’ characteristics

From: Microvascular alterations in patients with SARS-COV-2 severe pneumonia

Male (n,  %)10 (83.3%)
Age (years)56 (10)
BMI (kg/m2)31.6 (5.4)
Comorbidities (n, %)
 Dyslipidemia4 (33.3%)
 Hypertension3 (25.0%)
 Diabetes type 22 (16.7%)
 Ischemic cardiomyopathy2 (16.7%)
Tidal volume (ml)421 (190)
RR (breath/min)13 (3)
Pplat (cmH2O)27 (5)
PEEP (cmH2O)10 (8.6; 13.8)
∆P (cmH2O)13 (4)
Cstat (ml/cmH2O)52 (37)
FiO20.40 (0.35; 0.48)
PaO2/FiO2 (mmHg)207 (88)
VV-ECMO (n,  %)6 (50.0%)
CRRT (n,  %)2 (16.7%)
MAP (mmHg)88 (13)
HR (beat/min)86 (23)
Lactate (mmo/l)1.16 (0.41)
WBC (×109/l)14.12 (5.13)
IL-6 (pg/ml)138 (18.5; 338)
D-Dimer (ng/ml)788 (717; 5536)
Noradrenaline
 n (%)9 (75%)
 mcg/kg/min0.24 (0.14)
Propofol
 n (%)9 (75%)
 mg/kg/h2.5 (0.46)
Midazolam
 n (%)9 (75%)
 mg/kg/h0.26 (0.12)
Remifentanil
 n (%)12 (100%)
 mcg/kg/min0.1 (0.85; 0.1)
  1. Data reported as n. (%); mean (standard deviation); median (interquartile range)
  2. BMI body mass index, CRRT continuous renal replacement therapy, Cstat static compliance of respiratory system, FiO2 inspiratory fraction of oxygen, HR heart rate, IL-6 interleukin 6, MAP mean arterial pressure, PaO2 arterial partial pressure of oxygen, ∆P driving pressure, PEEP positive end expiratory pressure, Pplat plateau pressure, RR respiratory rate, VV-ECMO veno-venous extracorporeal membrane oxygenation, WBC white blood cells